Renocare Pharmaceuticals Private Limited, a active private limited company, was established on 26 June 2009 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230TN2009PTC072103. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.80 M and a paid-up capital of ₹1.67 M.
It upholds a compliant status. Employing 120 professional, Its leadership includes Tiruvallur Echambadi Asshok Iyengar (Managing Director), Vividh Ashok Tiruvallur Echambadi (Director), Ashok Iyengar Harrsha (Director). Past directors included Cootam Raman Padmalatha, Vividh Ashok Tiruvallur Echambadi, Ashok Iyengar Harrsha. It holds ₹2.39 Cr open charges and ₹4.00 M settled loans. Its latest AGM occurred on 21 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plat No.Rf-6, I Floor,Abhi-Ani Terrace, Plot No.22,Gangai Amman Koil Iv Street,, Vadapalani, Chennai, Tamil Nadu, 600026.
U24230TN2009PTC072103
072103
26 June 2009
₹1.80 M
₹1.67 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Renocare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tiruvallur Echambadi Asshok Iyengar | Managing Director | 04 Sep 2016 | Current |
| Vividh Ashok Tiruvallur Echambadi | Director | 21 Sep 2022 | Current |
| Ashok Iyengar Harrsha | Director | 21 Sep 2022 | Current |
| Ashok Hemma | Director | 18 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Jul 2023 | Past |
| Pramod Abcsdd | Director | 05 Apr 2018 | Past |
| Pramod Abcsdd | Director | 05 Apr 2018 | Past |
| Pramod Abcsdd | Director | 12 Jul 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Renocare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.23% increase. The company also saw a substantial fall in profitability, with a 25.49% decrease in profit. The company's net worth Soared by an impressive increase of 65.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Renocare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹23,856,916.00
₹4,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2024 | State Bank Of India | ₹2.00 Cr | Open |
| 30 Oct 2023 | Hdfc Bank Limited | ₹2.51 M | Open |
| 14 Dec 2021 | Hdfc Bank Limited | ₹1.35 M | Open |
| 16 Jul 2012 | Axis Bank Limited | ₹4.00 M | Satisfied |
Explore comprehensive loan charge details -
Renocare Pharmaceuticals has a workforce of 120 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Renocare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renocare Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Renocare Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records. was completed.
The activity Renocare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.
Progress on A charge with State Bank Of India amounted to Rs. 20.00 M with Charge ID 101027102 was registered on 11 Dec 2024. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.51 M with Charge ID 100848296 was registered on 30 Oct 2023. was documented.
Progress on Vividh Ashok Tiruvallur Echambadi was appointed as a Director was appointed as a Director on 21 Sep 2022 & has been associated with this company since 3 years 2 months . was documented.
Ashok Iyengar Harrsha was appointed as a Director was appointed as a Director on 21 Sep 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.
The CIN of Renocare Pharmaceuticals Private Limited is U24230TN2009PTC072103.
Renocare Pharmaceuticals Private Limited is headquartered at Plat No.Rf-6, I Floor,Abhi-Ani Terrace, Plot No.22,Gangai Amman Koil Iv Street,, Vadapalani, Chennai, Tamil Nadu, 600026.
Renocare Pharmaceuticals Private Limited was incorporated on 26 June 2009.
The current directors of Renocare Pharmaceuticals Private Limited are
The primary industry of Renocare Pharmaceuticals Private Limited is Trade.
Renocare Pharmaceuticals Private Limited is unlisted.
The authorized capital of Renocare Pharmaceuticals Private Limited is ₹1.80 M, and the paid-up capital is ₹1.67 M.
The compliance status of Renocare Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX